RevMAb Biosciences' Unattributed - II Round

RevMAb Biosciences raised a round of funding on April 08, 2016.

RevMAb Biosciences USA has developed a monoclonal antibody generation method which allows development of monoclonal antibodies without generation of hybridoma. The antibodies are developed from a broa…

Articles about RevMAb Biosciences' Unattributed - II Round: